NCT00521521View on ClinicalTrials.gov

Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

May 31, 2006

Conditions
Head and Neck Neoplasms
Interventions
DRUG

docetaxel and cisplatin

DRUG

docetaxel

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00521521 - Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter